TWST - Twist Bioscience Corp
48.66
0.600 1.233%
Share volume: 1,171,695
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$48.06
0.60
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 05-02-2024 | 08-02-2024 | 02-03-2025 | 02-03-2025 | 05-05-2025 | 08-04-2025 | 11-17-2025 | 02-02-2026 | |
| Assets | |||||||||
| Total Assets | 702.846 M | 638.118 M | 614.323 M | 608.580 M | 595.615 M | 643.605 M | 641.861 M | 638.085 M | |
| Current Assets | 371.869 M | 361.831 M | 346.776 M | 345.309 M | 338.442 M | 339.776 M | 332.966 M | 303.882 M | |
| Inventories | 30.376 M | 28.484 M | 24.078 M | 23.518 M | 20.860 M | 25.938 M | 28.309 M | 32.924 M | |
| Other Current Assets | 12.158 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 12.158 M | 50.276 M | 50.083 M | 49.424 M | 46.710 M | 49.425 M | 49.385 M | 49.358 M | |
| Total Receivables | 35.993 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 293.342 M | 239.142 M | 226.316 M | 221.403 M | 210.437 M | 201.373 M | 183.049 M | 148.591 M | |
| Total Non-current Assets | 330.977 M | 0.000 | 0.000 | 0.000 | 0.000 | 54.337 M | 54.337 M | 54.337 M | |
| Property Plant Equipment | 121.339 M | 106.339 M | 102.520 M | 100.669 M | 97.143 M | 95.351 M | 102.283 M | 105.119 M | |
| Other Assets | 5.395 M | 169.948 M | 165.027 M | 162.602 M | 160.030 M | 208.478 M | 206.612 M | 229.084 M | |
| Intangible Assets | 51.898 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 85.811 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 702.846 M | 638.118 M | 614.323 M | 608.580 M | 595.615 M | 643.605 M | 641.861 M | 638.085 M | |
| Total liabilities | 142.715 M | 146.979 M | 141.634 M | 152.639 M | 155.507 M | 165.407 M | 168.903 M | 181.990 M | |
| Total current liabilities | 67.490 M | 73.757 M | 71.006 M | 69.646 M | 74.976 M | 87.070 M | 91.406 M | 80.441 M | |
| Accounts Payable | 7.703 M | 6.626 M | 1.630 M | 7.503 M | 8.063 M | 11.985 M | 11.094 M | 12.493 M | |
| Other liabilities | 421.000 K | 73.222 M | 70.628 M | 67.993 M | 65.531 M | 63.337 M | 62.497 M | 86.549 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 421.000 K | 73.222 M | 70.628 M | 67.993 M | 65.531 M | 63.337 M | 62.497 M | 86.549 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 560.131 M | 491.139 M | 472.689 M | 455.941 M | 440.108 M | 478.198 M | 472.958 M | 456.095 M | |
| Common stock | 57.779 M | 1.699 B | 1.715 B | 1.730 B | 1.754 B | 1.772 B | 1.793 B | 1.807 B | |
| Retained earnings | -1.122 B | -1.207 B | -1.242 B | -1.274 B | -1.313 B | -1.292 B | -1.320 B | -1.350 B |